Literature DB >> 20478111

Metabolic syndrome: clinical and angiographic impact on patients with acute coronary syndrome.

Alejandra Madrid Miller1, Antonio Alcaraz Ruiz, Gabriela Borrayo Sánchez, Eduardo Almeida Gutiérrez, Rosa María Vargas Guzmán, Ricardo Jáuregui Aguilar.   

Abstract

BACKGROUND: Metabolic syndrome (MetS) is represented by a cluster of various risk factors and is one of the most important public health problems of the 21st century. The aim of this study was to identify the impact of this syndrome in patients with acute coronary syndrome (ACS).
METHODS: We included patients with ST and non-ST segment elevation ACS. We divided patients into two groups: A) patients with MetS criteria and B) patients without MetS criteria. We compared the incidence of major cardiovascular events, severity of coronary artery disease (CAD), need for urgent revascularization and in-hospital mortality between groups.
RESULTS: Among 917 patients with ACS, 421 (43.4%) fulfilled criteria of MetS. Age of patients in this group was 63.37 +/- 9.95 years (compared with 61.77 +/- 12.20 years in group B), 66.7% vs. 72.8% males, diabetes 70.3% vs. 33.3%, hypertension 87.6% vs. 40.5% and dyslipidemia 70.5% vs. 26.9%, respectively. ST-elevation ACS was more frequent in group A. We observed more severe CAD, and major cardiovascular events were more frequent in group A. Multivariate analysis demonstrated that hyperfibrinogenemia, hyperglycemia and MetS were independent predictors of heart failure and combined end point.
CONCLUSIONS: Incidence of MetS was high in patients with ACS, presented with more comorbidities and older patients, and was associated with poorer in-hospital outcome. It may be probable that the high inflammatory and prothrombotic response and more severe CAD in these patients increase the incidence of major cardiovascular events.

Entities:  

Mesh:

Year:  2010        PMID: 20478111

Source DB:  PubMed          Journal:  Cir Cir        ISSN: 0009-7411            Impact factor:   0.361


  5 in total

1.  Prevalence of metabolic syndrome components in an urban Mexican sample: comparison between two classifications.

Authors:  Irma Isordia-Salas; David Santiago-Germán; Helem Rodrìguez-Navarro; Martín Almaráz-Delgado; Alfredo Leaños-Miranda; Francisco Anaya-Gómez; Gabriela Borrayo-Sánchez; Abraham Majluf-Cruz
Journal:  Exp Diabetes Res       Date:  2011-12-06

2.  Metabolic syndrome in the Mediterranean region: Current status.

Authors:  Panagiotis Anagnostis
Journal:  Indian J Endocrinol Metab       Date:  2012-01

3.  Hypofibrinolytic State in Subjects with Type 2 Diabetes Mellitus Aggravated by the Metabolic Syndrome before Clinical Manifestations of Atherothrombotic Disease.

Authors:  Elsa Aburto-Mejía; David Santiago-Germán; Manuel Martínez-Marino; Eduardo Almeida-Gutiérrez; Mardia López-Alarcón; Jesús Hernández-Juárez; Antonio Alvarado-Moreno; Alfredo Leaños-Miranda; Abraham Majluf-Cruz; Irma Isordia-Salas
Journal:  Biomed Res Int       Date:  2017-02-08       Impact factor: 3.411

4.  The importance of two metabolic syndrome diagnostic criteria and body fat distribution in predicting clinical severity and prognosis of acute myocardial infarction.

Authors:  Marko Mornar Jelavic; Zdravko Babic; Hrvoje Pintaric
Journal:  Arch Med Sci       Date:  2016-05-05       Impact factor: 3.318

5.  Impact of Metabolic Syndrome and It's Components on Prognosis in Patients With Cardiovascular Diseases: A Meta-Analysis.

Authors:  Xiao Li; Yajing Zhai; Jiaguo Zhao; Hairong He; Yuanjie Li; Yue Liu; Aozi Feng; Li Li; Tao Huang; Anding Xu; Jun Lyu
Journal:  Front Cardiovasc Med       Date:  2021-07-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.